RxDoctor Payments Data

Melissa Lumpkin

Family · Covington, LANPI 1306181466

Payments from drug & device makers

$1,286in general payments, 2019–2025

Across 66 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$263
  • Lilly USA, LLC$157
  • AbbVie$131
  • Itamar Medical Inc$111
  • Pfizer$104
  • Abbott$80
  • plus $440 from 14 others

What the payments were for

  • Food & beverage$1,286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,286 in reported general payments places this provider in the 65th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$26,487
Medicare patients
126
Services billed
319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin34$34,534
MounjaroTirzepatide13$23,459
OzempicSemaglutide14$19,576
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$13,940
TradjentaLinagliptin15$11,421
LinzessLinaclotide14$9,644
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,714
Albuterol Sulfate HfaAlbuterol Sulfate44$2,032
SynthroidLevothyroxine Sodium14$1,532
Levothyroxine Sodium167$1,329
Atorvastatin Calcium162$1,300
Pantoprazole Sodium86$820
Rosuvastatin Calcium49$646
Bupropion XlBupropion Hcl37$620
Escitalopram Oxalate39$604

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$37$45,95549 claims
Lilly USA, LLCMounjaro$157$23,45913 claims
Novo NordiskOzempic$263$19,57614 claims
GSKTrelegy Ellipta$35$13,94022 claims
AbbVieLinzess, Synthroid$131$11,17528 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,610 family providers in Louisiana.

Other family in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →